GRAL · GRAIL, Inc.

Track GRAL — free

$75.11 -0.78 (-1.03%) At close · Sep 16

Russell 2000 member Rebalance outlook locked

Market Cap

$3.37B

44.67M

Up next

Next earnings call

Nov 3, 2026 Est · unconfirmed · in 7 wks

Latest filing: 10-Q

filed Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$165.26M

Trailing 12 months

Net income (TTM)

−$391.59M

Trailing 12 months

Revenue growth YoY

+25.7%

Year over year

Operating margin

-338.4%

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

-8.8%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

$55.65M

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+20.4%

Year over year · more shares

Price change (1Y)

+93.0%

Trailing year

Short interest

19.1%

Latest settlement · 12.3 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Buy Momentum Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 17.7 · elevated Equity put/call 0.69

Technical

price trend

Buy

50 / 200-day cross Golden cross

Price vs 200-day avg +4%

above

Price vs 50-day avg +2%

above

RSI (14) 48

neutral

MACD trend Negative

52-week position 47%

mid-range

Momentum

relative strength

Strong

1-month return +6%

trailing

6-month return +44%

trailing

YTD return −12%

this year

Relative strength +29%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) Golden cross

50d $74 › 200d $72 — 50d above 200d

Institutional flow Accumulating

+5% holders QoQ · +71 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

19.06% of float · ▲ +4.4% MoM · 12.3 days cover

Volume signal Reversal watch

High volume on a down day — possible exhaustion

Institution breadth Steady

380 holders — mid 2-yr range

Squeeze score 73

high risk · 0–100

Fundamentals

Strong

Revenue growth +17%

Y/Y

EPS growth +83%

Y/Y

Free cash flow $-299.9M

Quant / Vol

risk profile

Very High

Volatility 100%

annualized · 1-yr

Max drawdown −63%

past year

ATR 5.7%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the Earnings Call filed Mar 31, 2026

Revenue growth · the year 22% – 32%

Prior guidance period ended · from the 8-K filed Aug 13, 2024

Burn · 2025 $325M

Savings, net of anticipated severance and benefits costs · 2024 $27M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy

1 · 2 · 3

50 / 200-day cross

Golden cross Bullish

Price vs 200-day avg

+4% Bullish

Price vs 50-day avg

+2% Bullish

RSI (14)

48 Neutral

MACD trend

Negative Bearish

52-week position

47% Neutral

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) Golden cross

50d $74 › 200d $72 — 50d above 200d

Institutional flow Accumulating

+5% holders QoQ · +71 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

19.06% of float · ▲ +4.4% MoM · 12.3 days cover

Volume signal Reversal watch

High volume on a down day — possible exhaustion

Institution breadth Steady

380 holders — mid 2-yr range

Price context

position in its 52-week range

Range low $38 Now $75 · 47% Range high $116

vs 200-day avg +4% vs 50-day avg +2% 50-day above 200-day golden cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Diagnostics & Research — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
GRAL GRAIL, Inc. this stock	$3.37B	-12.2%	+17.2%	—	19.1%
TMO Thermo Fisher Scientific Inc.	$235.29B	+11.9%	+14.5%	34.2	1.5%
DHR Danaher Corp /De/	$147.37B	-9.0%	+8.5%	37.2	1.4%
NTRA Natera, Inc.	$49.27B	+50.7%	-2.8%	—	3.8%
IQV Iqvia Holdings Inc.	$44.34B	+19.3%	+41.6%	33.0	2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

380

% held: 89.4%
Net QoQ: +4.3M sh
Top holder: FARALLON CAPITAL MANAGEME…

Held Float

View

Held by Funds

Fund positions

236

View

Short & Settlement

Short Interest Rising

Shares short

8.5M

Days to cover: 12.3d
Change: +357.2K sh

View

Short Volume

Short vol %

65%

As of: Sep 16, 2026

Short Total

View

Fails to Deliver

FTD shares

2.5K

Value: $201.8K
As of: Aug 24, 2026

View

Off-Exchange

Off-exchange %

43.5%

Week of: Aug 10, 2026

Off-exch Lit

View

Financials

Revenue (FY)

$147.2M

Net income (FY): $-408.4M
EPS diluted: $-11.11

View

Filings

SEC Filings

Latest

Investor Event Transcript

Filed: Aug 11, 2026
This year: 12

View

Proposed Sales

Value

$795.9K

Shares: 10.0K
Filed: Aug 27, 2026

View

Exempt Offerings

Offering

$325.0M

Filed: Nov 7, 2025

View

Earnings & Events

Earnings Calls

Last call

Aug 11, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
GRAL	-3.1%	+6.0%	+43.6%	-5.4%	-12.2%
SPY	-1.1%	-1.8%	+14.8%	-1.7%	+10.6%
vs SPY	-2.0%	+7.7%	+28.8%	-3.7%	-22.8%

Key facts CIK 1699031 CUSIP 384747101 13F (30d) 17 filings 16 filers Visit website Investor relations

GRAL · GRAIL, Inc.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance